Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | Day Return | YTD Return |
|---|---|---|---|
| All Industries | 100% | 0.52% | 6.55% |
| Drug Manufacturers - General | 34.15% | 0.73% | 12.68% |
| Healthcare Plans | 13.20% | 0.25% | -1.98% |
| Medical Devices | 12.96% | 1.30% | 8.73% |
| Biotechnology | 11.43% | 0.61% | -0.69% |
| Diagnostics & Research | 11.26% | 0.53% | 5.02% |
| Medical Instruments & Supplies | 6.73% | 1.01% | 8.34% |
| Medical Care Facilities | 2.86% | 0.96% | 12.51% |
| Drug Manufacturers - Specialty & Generic | 2.69% | 0.57% | -4.25% |
| Medical Distribution | 2.38% | 0.09% | 13.17% |
| Health Information Services | 2.05% | -7.91% | 7.56% |
| Pharmaceutical Retailers | 0.27% | 1.88% | -19.75% |
All Industries
-
Note: Percentage % data on heatmap indicates Day Return
Largest Companies in This Sector
Name | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 775.18 | 809.74 | 11.08% | Buy | ||||
| 492.06 | 593.70 | 6.82% | Buy | ||||
| 156.20 | 176.06 | 5.66% | Buy | ||||
| 130.22 | 135.54 | 4.96% | Buy | ||||
| 179.50 | 183.62 | 4.78% | Buy | ||||
| 574.30 | 597.91 | 3.32% | Buy | ||||
| 113.20 | 125.74 | 2.95% | Buy | ||||
| 248.50 | 260.70 | 2.76% | Buy | ||||
| 27.73 | 29.78 | 2.36% | Buy | ||||
| 282.99 | 284.99 | 2.28% | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 146.76 | 40.661B | 0.09% | ||
| 268.79 | 20.828B | 0.10% | ||
| 93.62 | 7.911B | 0.35% | ||
| 136.49 | 7.64B | 0.45% | ||
| 58.17 | 5.497B | 0.40% |
Mutual Fund Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 217.34 | 47.172B | 0.34% | ||
| 91.65 | 47.172B | 0.34% | ||
| 133.44 | 20.828B | 0.10% | ||
| 93.65 | 15.279B | 0.80% | ||
| 93.91 | 14.712B | 0.80% |
Healthcare Research
Discover the Latest Analyst and Technical Research for This Sector
Daily – Vickers Top Insider Picks for 03/27/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Buyers & Sellers for 03/27/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Analyst Report: Exact Sciences Corporation
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
RatingNeutralPrice TargetAnalyst Report: Haleon plc
Haleon is a pure-play consumer healthcare company focusing on oral health, respiratory health, pain relief, vitamins, supplements, and digestive health across 170 markets. Its products include consumer staples as well as over-the-counter medicines. Haleon was incorporated in 2021 and is headquartered in Brentford, UK.
RatingBullishPrice Target
